Back to Search

RONALD NATALE, M.D.

M.D.

Medical Oncology Physician

NPI: 1285734350Individual

Specialties, Licenses & Credentials

Specialist

Specialist

Code: 174400000X

C43090(CA)
Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

C43090(CA)

Research & Publications (20)

Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.
PMID 19332730·J Clin Oncol·2009
3-trial
Dual targeting of the vascular endothelial growth factor receptor and epidermal growth factor receptor pathways with vandetinib (ZD6474) in patients with advanced or metastatic non-small cell lung cancer.
PMID 18520295·J Thorac Oncol·2008
4-observational
A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine.
PMID 16291427·Lung Cancer·2005
6-review
Epidermal growth factor receptor-targeted therapy with ZD1839: symptom improvement in non-small-cell lung cancer.
PMID 15142633·Int J Radiat Oncol Biol Phys·2004
6-review
Effects of ZD1839 (Iressa, gefitinib) treatment on symptoms and quality of life in patients with advanced non-small cell lung cancer.
PMID 15206079·Semin Oncol·2004
6-review
Gemcitabine-containing regimens vs others in first-line treatment of NSCLC.
PMID 15339056·Oncology (Williston Park)·2004
6-review
Inhibition of epidermal growth factor receptor and symptom improvement in advanced non-small cell lung cancer.
PMID 16088518·Semin Respir Crit Care Med·2004
8-other
Irinotecan, cisplatin/carboplatin, and COX-2 inhibition in small-cell lung cancer.
PMID 12886870·Oncology (Williston Park)·2003
6-review
Biologically targeted treatment of non-small-cell lung cancer: focus on epidermal growth factor receptor.
PMID 14641989·Clin Lung Cancer·2003
6-review
Birth can be a hazardous journey: electronic fetal monitoring does not help.
PMID 14663534·J Obstet Gynaecol Can·2003
8-other
ZD1839 (Iressa): what's in it for the patient?
PMID 12202785·Oncologist·2002
6-review
Gemcitabine-based doublets for advanced non-small-cell lung cancer: beyond gemcitabine/cisplatin.
PMID 14720349·Clin Lung Cancer·2002
8-other
Gemcitabine and nonplatinum combinations in non-small-cell lung cancer.
PMID 11301844·Oncology (Williston Park)·2001
6-review
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
PMID 11122869·Curr Oncol Rep·2000
6-review
Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC.
PMID 10981288·Oncology (Williston Park)·2000
3-trial
Gemcitabine and taxane combinations in non small-cell lung cancer.
PMID 14725731·Clin Lung Cancer·2000
8-other
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.
PMID 19349543·J Clin Oncol·2009
3-trial
Risks and benefits of pacifiers.
PMID 19405412·Am Fam Physician·2009
6-review
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
PMID 19447868·Clin Cancer Res·2009
8-other
Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.
PMID 19517476·Cancer·2009
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
8700 BEVERLY BLVD, #AC1042B
WEST HOLLYWOOD, CA 90048

Location

Practice Location

8700 BEVERLY BLVD, WEST HOLLYWOOD, CA
(310) 423-1101

Quick Facts

NPI
1285734350
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile